Table 6. Multivariate logistic regression model for the related aspect of KAP for getting vaccinated minimal one dose and willingness to get vaccinated among respondents (N = 400).
| The aspect of Knowledge, Attitudes, and Practice | Have been vaccinated against HPV at least one dose | Intention and readiness to take HPV vaccination | ||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted OR (95%CI) | p-valuea | Adjusted OR (95%CI) | p-valuec | Unadjusted OR (95%CI) | p-valuea | Adjusted OR (95%CI) | p-valuec | |
| Good knowledge of: | ||||||||
| Etiology of CC | 3.29 (1.37–7.89) | 0.005 | 0.72 (0.19–2.79) | 0.639 | 1.75 (0.95–3.23) | 0.072 | 0.70 (0.27–1.79) | 0.456 |
| Overview and prior knowledge of HPV | 3.68 (1.86–7.26) | 0.000 | 1.21 (0.45–3.28) | 0.704 | 2.85 (1.63–4.99) | 0.000 | 1.60 (0.71–3.60) | 0.254 |
| HPV related malignancy | 2.93 (1.72–4.99) | 0.000 | 1.50 (0.74–3.02) | 0.257 | 1.68 (0.87–3.24) | 0.116 | 0.81 (0.28–2.37) | 0.694 |
| Transmission of HPV in men | 2.35 (1.34–4.12) | 0.002 | 0.73 (0.29–1.85) | 0.504 | 2.56 (1.44–4.54) | 0.001 | 1.18 (0.37–3.74) | 0.776 |
| Risk of HPV infection in men | 1.62 (0.97–2.73) | 0.067 | 0.59 (0.31–1.13) | 0.133 | 1.70 (0,95–3.06) | 0.072 | 0.71 (0.28–1.80) | 0.466 |
| Sex as a way to transmit HPV | 2.86 (1.41–5.80) | 0.003 | 1.71 (0.65–4.46) | 1.706 | 2.06 (1.17–3.62) | 0.011 | 1.49 (0.62–3.56) | 0.375 |
| The abundance of HPV infection | 3.22 (1.80–5.74) | 0.000 | 0.63 (0.27–1.48) | 0.289 | 1.73 (0.99–3.02) | 0.053 | 0.50 (0.23–1.12) | 0.093 |
| HPV can causes CC | 6.45 (2.28–18.19) | 0.000 | 1.49 (0.36–6.28) | 0.585 | 2.61 (1.47–4.64) | 0.001 | 1.32 (0.40–4.41) | 0.649 |
| Smoking as a risk of HPV infection | 1.86 (1.08–3.18) | 0.023 | 1.39 (0.72–2.70) | 0.325 | 1.79 (0.91–3.50) | 0.088 | 1.30 (0.49–3.42) | 0.601 |
| Vaccine to prevent CC | 16.22 (3.90–67.46) | 0.000 | 3.18 (0.68–14.97) | 0.143 | 1.81 (1.02–3.21) | 0.042 | 0.53 (0.22–1.28) | 0.155 |
| Availability of HPV vaccines | 6.21 (2.61–14.77) | 0.000 | 1.25 (0.36–4.29) | 0.724 | 2.25 (1.29–3.92) | 0.004 | 1.32 (0.48–3.64) | 0.592 |
| Accessibility to get HPV vaccines | 7.51 (3.16–17.84) | 0.000 | 3.20 (1.26–8.13) | 0.014 | 2.33 (1.34–4.05) | 0.002 | 1.21 (0.49–3.00) | 0.681 |
| Side effect of HPV vaccines | 0.97 (0.51–1.84) | 0.917 | - | n/a | 1.20 (0.59–2.42) | 0.617 | - | n/a |
| Risk of infection after vaccination | 2.20 (1.29–3.77) | 0.003 | 0.82 (0.38–1.74) | 0.600 | 2.92 (1.58–5.37) | 0.000 | 1.86 (0.84–4.13) | 0.125 |
| Neccesity of HPV vaccine for infected-people | 1.02 (0.59–1.75) | 0.957 | - | n/a | 1.54 (0.83–2.84) | 0.166 | 1.02 (0.42–2.48) | 0.973 |
| Screening still needed for HPV-vaccinated people | 2.61 (1.24–5.46) | 0.009 | 1.18 (0.46–3.03) | 0.731 | 2.89 (1.64–5.11) | 0.000 | 1.41 (0.59–3.39) | 0.437 |
| The protection of HPV vaccination | 2.78 (1.58–4.89) | 0.000 | 0.95 (0.43–2.08) | 0.900 | 2.36 (1.32–4.20) | 0.003 | 2.71 (1.25–5.89) | 0.012 |
| Age-recommended for HPV vaccination | 6.39 (3.07–13.30) | 0.000 | 1.75 (0.73–4.19) | 0.212 | 2.47 (1.41–4.35) | 0.001 | 1.39 (0.57–3.40) | 0.464 |
| Dose-recommended for HPV vaccination | 6.44 (3.26–12.71) | 0.000 | 3.15 (1.50–6.58) | 0.002 | 3.20 (1.76–5.84) | 0.000 | 1.12 (0.41–3.04) | 0.826 |
| Not to having multiple sex partners after vaccination | 3.14 (1.55–6.37) | 0.001 | 0.81 (0.28–2.29) | 0.686 | 3.04 (1.73–5.32) | 0.000 | 1.97 (0.83–4.71) | 0.127 |
| Positive attitude of: | ||||||||
| HPV infection perceived as a dangerous virus | 6.68 (1.59–28.06) | 0.003 | 3.55 (0.77–16.36) | 0.104 | 3.31 (1.74–6.31) | 0.000 | 2.89 (1.22–6.87) | 0.016 |
| HPV infection susceptibility | 1.23 (0.71–2.13) | 0.455 | - | n/a | 2.52 (1.23–5.16) | 0.009 | 1.51 (0.62–3.69) | 0.362 |
| Worries about CC risk in partner and family | 1.42 (0.53–3.77) | 0.483 | - | n/a | 4.00 (1.94–8.30) | 0.000 | 2.73 (0.98–7.61) | 0.055 |
| Support vaccination for children | 0.72 (1.47–3.56) | 0.657b | - | n/a | 2.93 (0.71–12.05) | 0.139b | 0.91 (0.10–8.64) | 0.934 |
| Support vaccination for adults | indefinite | 0.223b | - | n/a | 4.42 (0.96–20.28) | 0.072b | 1.43 (0.13–15.98) | 0.769 |
| Willingness to get HPV vaccines | 7.13 (2.18–23.29) | 0.000 | 4.73 (1.36–16.50) | 0.015 | 9.13 (5.01–16.63) | 0.000 | 6.61 (3.16–13.83) | 0.000 |
| Suggestion of vaccination for partner and family | 0.83 (0.41–1.70) | 0.609 | - | n/a | 4.22 (2.23–7.99) | 0.000 | 1.10 (0.37–3.27) | 0.871 |
| Not fear of injection in general | 1.97 (1.03–3.77) | 0.037 | 0.94 (0.43–2.09) | 0.882 | 1.63 (0.92–2.88) | 0.093 | 0.80 (0.35–1.84) | 0.603 |
| No worriness about side effect of HPV vaccines | 7.66 (3.88–15.12) | 0.000 | 4.63 (2.25–9.54) | 0.000 | 2.07 (1.16–3.69) | 0.012 | 1.82 (0.82–4.04) | 0.140 |
| No fear of HPV vaccination | 13.26 (1.80–97.54) | 0.001 | 6.75 (0.86–53.18) | 0.070 | 4.85 (2.56–9.17) | 0.000 | 3.65 (1.59–8.37) | 0.002 |
| Favorable practice of: | ||||||||
| Decision is controled by parents | 1.86 (1.09–3.16) | 0.022 | 0.69 (0.36–1.33) | 0.269 | 0.85 (0.49–1.46) | 0.547 | - | n/a |
| Decision is influenced by friends | 1.09 (0.57–2.12) | 0.791 | - | n/a | 0.77 (0.37–1.60) | 0.484 | - | n/a |
| Religions support HPV vaccination | 1.61 (0.70–3.72) | 0.259 | - | n/a | 2.05 (1.04–4.03) | 0.035 | 1.09 (0.37–3.17)/ | 0.878 |
| Sharing knowledge about HPV and CC | indefinite | 0.012b | - | n/a | 20.39 (8.04–51.68) | 0.000 | 12.36 (3.78–40.43) | 0.000 |
| Intention to know more about HPV, CC, vaccine | 1.70 (0.38–7.58) | 0.750b | - | n/a | 18.53 (6.32–54.33) | 0.000b | 9.17 (2.29–36.71) | 0.002 |
aBivariate analysis using Chi-square and bFisher’s exact test which any associated factors with p≤0.20 were deemed eligible for inclusion in the multivariate analysis model; cMultivariate logistic regression analysis; Indefinite results caused by the presence of zero proportion. CC, Cervical cancer; 95%CI (95% confidence intervals).